<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04339530</url>
  </required_header>
  <id_info>
    <org_study_id>7062019</org_study_id>
    <nct_id>NCT04339530</nct_id>
  </id_info>
  <brief_title>Vitamin D and Type 2 Diabetes Risk in UK Adults</brief_title>
  <official_title>Association Between Vitamin D Status and Risk of Type 2 Diabetes in a Population of UK Adults: A Cross-sectional Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Liverpool Hope University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Liverpool Hope University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is exploring the association between vitamin D and Type 2 diabetes risk in normal
      weight and overweight UK adults.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to assess the link between vitamin D status and glucose homeostasis
      in a population of normal weight and overweight individuals (BMI&gt; 18.5 Kg/m2).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HOMA-IR (Homeostasis modelling assessment-Insulin resistance)</measure>
    <time_frame>One venous sample collected after 8 hours of fasting</time_frame>
    <description>A venous blood sample collected for the measurement of insulin and glucose levels.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting bood glucose levels</measure>
    <time_frame>One venous sample collected after 8 hours of fasting</time_frame>
    <description>A venous blood sample collected for the measurement of glucose levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1C</measure>
    <time_frame>Sample collected at one single time point with no follow-up</time_frame>
    <description>Fingerprick sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat percentage</measure>
    <time_frame>Measurement conducted in the morning after 8 hours of fasting</time_frame>
    <description>Body fat percentage measured through DEXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central and brachial Systolic and Diastolic Blood pressure</measure>
    <time_frame>Measurement taken 3 times after a-10 minute rest</time_frame>
    <description>Blood pressure measured using a digital sphygmomanometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Augmentation index</measure>
    <time_frame>Measurement taken 3 times after a-10 minute rest</time_frame>
    <description>Arterial stiffness assessment test</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal weight and overweight adults</intervention_name>
    <description>Association between vitamin D levels and insulin resistance</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Overweight and obese adults , aged 18-50 (premenopausal women), males and females with no
        known chronic conditions.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal weight and overweight and obese adults (BMI&gt;= 18.5 Kg/m2) with no restriction
             to ethnicity, occupation or socioeconomic status.

          -  Males and females

          -  18-50 years

        Exclusion Criteria:

          -  Patients diagnosed with diabetes type 2, myocardial infarction or coronary heart
             disease.

          -  HbA1c &gt; 6.4%

          -  Pregnancy

          -  Diagnosis of liver disease (including liver enzymes &gt; 3 times above normal values)

          -  Diagnosis of renal disease (creatinine of &gt; 150 mmol/l)

          -  Post-menopausal women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Grace Farhat, PhD</last_name>
    <phone>0151 291 3592</phone>
    <email>farhatg@hope.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>School of Health sciences</name>
      <address>
        <city>Liverpool</city>
        <zip>L1 9JD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farzad Amirabdollahian, PhD</last_name>
      <phone>0151 291 3799</phone>
      <email>amirabf@hope.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 3, 2020</study_first_submitted>
  <study_first_submitted_qc>April 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2020</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Liverpool Hope University</investigator_affiliation>
    <investigator_full_name>Grace Farhat</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Insulin resistance</keyword>
  <keyword>Glucose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

